IMCTA-C14

IMCTA-C14 is an N-tetradecyl (C14) derivative of trehalosamine, a bacterial metabolite.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

IMCTA-C14 is an N-tetradecyl (C14) derivative of trehalosamine, a bacterial metabolite. It was synthesized as a sugar-based surfactant containing a trehalose substructure from the condensation of 4-trehalosamine and tetradecanal. Its surfactant properties are not very different from those of other sugar-based surfactant with aliphatic chains of similar length.

However, IMCTA-C14 shows similar biological activity to trehalose at low concentrations. For the induction of autophagy in cultured cells, trehalose is required at a high concentration of about 10-100 mM. In contrast, IMCTA-C14 shows similar activity at about 1/3000 of that concentration.

To illustrate this, expression of the metabolic clock gene, Period 1, was induced more strongly in cultured hepatocytes at a concentration 1/1000 that of trehalose. The reason for its strong biological activity is thought to be that it has a fatty chain length similar to that of the phospholipids that make up the cell membrane, and a highly basic secondary amine.

This gives it a strong affinity for the cell membrane, thereby enhancing its proximity to and effect on the glucose transporter and sweet taste receptor, membrane proteins, the functions of which are modulated by trehalose and other carbohydrates.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1369640033 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.